Incidental Thyroid Neuroendocrine Carcinoma Revealing a Presumed Occult Gastrointestinal Malignancy
- 1Department of Otolaryngology-Head and Neck Surgery, Atrium Health Wake Forest Baptist, Winston-Salem, USA
- 2Department of Pathology, Wake Forest School of Medicine, Winston-Salem, USA
- 3Department of Endocrinology, Atrium Health Wake Forest Baptist, Winston-Salem, USA
Abstract
In rare cases, a thyroid mass may represent metastatic neuroendocrine disease rather than a primary thyroid malignancy. This case report describes a unique presentation of neuroendocrine carcinoma involving the thyroid with concurrent somatostatin receptor-positive gastrointestinal and mesenteric lesions of uncertain origin, providing insight into the diagnostic and management challenges of this disease. We present a 60-year-old male patient found to have an incidental 11 cm left thyroid mass with airway displacement on neck computed tomography (CT). A left thyroid lobectomy was performed, and surgical pathology confirmed neuroendocrine carcinoma. Immunohistochemical and molecular testing argued against medullary thyroid carcinoma, while site-of-origin markers created a diagnostic challenge with features suggestive of both pulmonary and non-pulmonary origin. Subsequent DOTATATE positron emission tomography (PET) scan demonstrated somatostatin receptor-avid lesions involving the duodenum and mesentery, raising the possibility of a gastrointestinal primary with metastatic spread to the thyroid. The discordance between the immunohistochemical profile and imaging findings highlights the diagnostic complexity of neuroendocrine tumors involving the thyroid and underscores the importance of comprehensive systemic evaluation, including functional imaging and site-of-origin immunohistochemistry, in the setting of atypical thyroid pathology. Prompt recognition of potential systemic neuroendocrine malignancy is essential for staging and therapeutic planning.
Related
- Incidental pulmonary nodules detected on computed tomography pulmonary angiography: prevalence and malignancy outcomes from a Thai tertiary-care center
- When Every Test Fails: Multifocal Grade 1 Ileal Neuroendocrine Tumors Causing Transfusion-Dependent Obscure Overt Gastrointestinal Bleeding.
- Incidental Detection of Bilateral Node-Positive Papillary Thyroid Carcinoma During Initial Staging for Localized Testicular Seminoma: A Case Report
- 455 Second primary malignancy risk in the immunotherapy era among urothelial carcinoma survivors: a SEER population-based analysis
- Squamous cell carcinoma of the clitoris: a rare vulvar malignancy treated with surgery and adjuvant radiotherapy.
BibTeX
@article{walker2026incidental,
title = {{Incidental Thyroid Neuroendocrine Carcinoma Revealing a Presumed Occult Gastrointestinal Malignancy}},
author = {Rebecca J Walker and Fatima Z Aly and Matthew Gorris and Allison Slijepcevic and Christopher A Sullivan},
journal = {Cureus},
year = {2026},
month = oct,
doi = {10.7759/cureus.117310},
url = {https://europepmc.org/article/PMC/PMC13723298},
note = {CC BY},
}
RIS
TY - JOUR
TI - Incidental Thyroid Neuroendocrine Carcinoma Revealing a Presumed Occult Gastrointestinal Malignancy
AU - Rebecca J Walker
AU - Fatima Z Aly
AU - Matthew Gorris
AU - Allison Slijepcevic
AU - Christopher A Sullivan
PY - 2026
DA - 2026/10/01
JO - Cureus
DO - 10.7759/cureus.117310
UR - https://europepmc.org/article/PMC/PMC13723298
AB - In rare cases, a thyroid mass may represent metastatic neuroendocrine disease rather than a primary thyroid malignancy. This case report describes a unique presentation of neuroendocrine carcinoma involving the thyroid with concurrent somatostatin receptor-positive gastrointestinal and mesenteric lesions of uncertain origin, providing insight into the diagnostic and management challenges of this disease. We present a 60-year-old male patient found to have an incidental 11 cm left thyroid mass with airway displacement on neck computed tomography (CT). A left thyroid lobectomy was performed, and surgical pathology confirmed neuroendocrine carcinoma. Immunohistochemical and molecular testing argued against medullary thyroid carcinoma, while site-of-origin markers created a diagnostic challenge with features suggestive of both pulmonary and non-pulmonary origin. Subsequent DOTATATE positron emission tomography (PET) scan demonstrated somatostatin receptor-avid lesions involving the duodenum and mesentery, raising the possibility of a gastrointestinal primary with metastatic spread to the thyroid. The discordance between the immunohistochemical profile and imaging findings highlights the diagnostic complexity of neuroendocrine tumors involving the thyroid and underscores the importance of comprehensive systemic evaluation, including functional imaging and site-of-origin immunohistochemistry, in the setting of atypical thyroid pathology. Prompt recognition of potential systemic neuroendocrine malignancy is essential for staging and therapeutic planning.
SN - 2168-8184
ER -